Single life time cytological screening in high risk women as an economical and feasible approach for controlling cervical cancer in developing countries like India

International Conference on Cytopathology

August 31-September 02, 2015 Toronto, Canada

J S Misra

Era�s Lucknow Medical College and Hospital, India

Posters-Accepted Abstracts: J Cytol Histol

Abstract :

Aims & Objective: In view of funding crunch and inadequate manpower in cytology in developing countries like India, single lifetime screening for cervical cancer has been suggested. In this study, an attempt was made to identify high risk groups of women for this screening to make it more effective for early detection. Materials & Methods: Cytological data were derived from the ongoing routine cervical cytology screening program for women attending Gynaecology OP Department of Queen Mary�s Hospital of KG Medical University, Lucknow, India during a span of 35 years (April 1971-December 2005). Results: Cervical smears in a total of 38,256 women were cytologically evaluated. The frequencies of squamous intraepithelial lesions of cervix (SIL) and carcinoma cervix were found to be 7.0% and 0.6% respectively in the series. Predisposing factors related to cervical carcinogenesis were analyzed in detail to establish the most vulnerable groups of women for single life time screening. The incidence of SIL and carcinoma cervix was found to be maximal in women above the age of 40 years irrespective of parity and in multiparous women (with three or more children) irrespective of age. The incidence of cervical cytopathologies was significantly higher in symptomatic women, the frequency of SIL being alarmingly higher in women complaining of contact bleeding and that of carcinoma cervix in older women with postmenopausal bleeding. Conclusion: It is consequently felt that single life time screening must include the three groups of women delineated above. Such selective screening appears to be the most economical, cost effective and feasible approach to control the menace of cervical cancer in developing countries like India.

Biography :

Email: jata_misra@rediffmail.com